G Medical Innovations management ‘razor focused’ on increasing revenue in 2023

G Medical Innovations Holdings issued an update to shareholders from President and CEO Dr. Yacov Geva. The company said, “We are proud to report that at this halfway point of 2023, G Medical has met several significant milestones and is on track to show revenue growth and gain profitability. Our Company has experienced growth in its monitoring services, and we are getting ready to add revenue with our “At Home Test Kits” business unit as we are now prepared to fully launch our fully stocked CLIA lab in Austin, TX…We have made some significant changes to our corporate team which we believe will streamline our business while aiming to better manage our financial and business operations towards more control and improved compliance. In June 2023 David Seligman, a seasoned and experienced CFO, joined our management team. Mr. David Seligman has more than 27 years of experience as CFO including 4 public companies traded on Nasdaq as well as several privately held startup companies. Prior to this he was senior financial analyst for Fidelity Investment System Company in Boston, MA. We replaced our external auditors and appointed PwC International Limited instead of BDO Israel. We appointed Ms. Rina Bar as our Corporate Marketing VP. Ms. Bar has over 23 years of experience in marketing, sales and business development, spanning healthcare, medical devices and pharmaceutical industries. We appointed Mr. Shane Julian as EVP of Corporate Business Development. Mr. Julian has over 20 years of experience in healthcare leadership for large healthcare organizations across the US. He brings extensive experience in business development, strategic forecasting, and clinical expertise…Our management team is razor focused on increasing revenue during 2023 and we are looking forward to an even brighter 2024 and beyond. The management team understands the challenges and opportunities in front of us and are confident of being on a path to growing revenue.”